References and Notes
1
Harada S.
Kowase N.
Tabuchi N.
Taguchi T.
Dobashi Y.
Dobashi A.
Hanzawa Y.
Tetrahedron
1998,
54:
753
2
Ley SV.
Middleton B.
Chem. Commun.
1998,
1995
3
Fugami K.
Morizawa Y.
Ishima K.
Nozaki H.
Tetrahedron Lett.
1985,
26:
857
4
Ahman J.
Somfai P.
J. Am. Chem. Soc.
1994,
116:
9781
5
Hassner A.
Chau W.
Tetrahedron Lett.
1982,
23:
1989
6
Atkinson RS.
Ayscough AP.
Gattrell WT.
Raynham TM.
Tetrahedron Lett.
1998,
39:
497
7
Wipf P.
Fritch PC.
J. Org. Chem.
1994,
59:
4875
8
Cantrill AA.
Jarvis AN.
Osborn HMI.
Ouadi A.
Sweeney JB.
Synlett
1996,
847
9a
Li A.-H.
Dai L.-X.
Hou X.-L.
Chem. Commun.
1996,
491
9b
Li A.-H.
Dai L.-X.
Hou X.-L.
Chen M.-B.
J. Org. Chem.
1996,
61:
4641
9c
Wang D.-K.
Dai L.-X.
Hou X.-L.
Chem. Commun.
1997,
1231
9d
Li A.-H.
Zhou Y.-G.
Dai L.-X.
Hou X.-L.
Xia L.-J.
Tang M.-H.
J. Org. Chem.
1998,
63:
4338
9e
Hou X.-L.
Yang X.-F.
Dai L.-X.
Chen X.-F.
Chem. Commun.
1998,
747
9f
Arini LG.
Sinclair A.
Szeto P.
Stockman RA.
Tetrahedron Lett.
2004,
45:
1589
9g
Morton D.
Pearson D.
Field RA.
Stockman RA.
Org. Lett.
2004,
6:
2377
9h
Morton D.
Pearson D.
Field RA.
Stockman RA.
Chem. Commun.
2006,
1833
10
Zheng J.-C.
Liao W.-W.
Sun X.-X.
Sun X.-L.
Tang Y.
Dai L.-X.
Deng J.-G.
Org. Lett.
2005,
7:
5789 ; and references therein
11
Huisman M.
ten Have R.
van Leusen AM.
Synth. Commun.
1997,
27:
945
12 Trimethylsulfoxoniummethylide has been reported to form an aziridine from a N-(dimethylsulfamoyl)ketimine: Hannam J.
Harrison T.
Heath F.
Madin A.
Merchant K.
Synlett
2006,
833
13
Typical Procedure for 1-(2′-Dimethylamine-2′-sulfonyl)-2-phenyl-3-vinylaziridine (2a)
Vacuum-dried sulfonium salt 1a (0.61 g, 2 equiv, 4.73 mmol) in DMSO, (15 mL) was stirred under argon.
N-(Dimethylsulfamoyl)phenylimine (0.48 g, 1 equiv, 2.26 mmol) in DMSO (8 mL) was added to the solution followed by LiOt-Bu, (0.38 g, 2 equiv, 4.45 mmol), and the progress of the reaction was monitored by TLC (25% EtOAc-PE). After 10 min the reaction was judged to be complete and was quenched with ice-cold brine, filtered through a pad of Celite and washed with Et2O. The resultant bilayer was separated and the aqueous layer was extracted with Et2O, the combined organic extracts were dried over anhyd Na2SO4, filtered, and concentrated under vacuum. Purification by flash column chromatography on neutral alumina, eluting with 5% EtOAc-PE, furnished (0.39 g, 66%) as a 2:1 mixture of trans/cis diastereomers. The separated aziridines were formed as a clear oil. Assignments are of the major trans isomer. IR (thin film): νmax = 1170, 1450, 2900 cm-1. MS (EI/Cl): m/z (%) = 253 (100) [M + H]. HRMS: m/z calcd for C12H16S1O2N2 [M + H]+: 253.1005; found: 253.1006. 1H NMR (400 MHz, CDCl3): δ = 7.40-7.20 (5 H, m), 6.2 (1 H, ddd, J = 9.6, 10.4, 16.8 Hz), 5.57 (1 H, dd, J = 0.8, 16.8 Hz), 5.45 (1 H, dd, J = 0.8, 10.4 Hz), 3.78 (1 H, d, J = 3.6 Hz), 3.18 (1 H, dd, J = 3.6, 9.6 Hz), 2.79 (6 H, s). 13C NMR (100 MHz, CDCl3): δ = 136.0, 131.9, 129.0, 128.6, 126.4, 122.8, 53.8, 49.6, 39.0.
1-(2′-Dimethylamine-2′-sulfonyl)-2-phenyl-3-propenyl-aziridine (2b)
Assignments are of the major diastereomer. IR (thin film): νmax = 1180, 1260, 1343, 1454 cm-1. MS (EI/Cl): m/z (%) 267 (47) [M + H], 145 (86), 60 (100). HRMS: m/z calcd for C13H18S1O2N2 [M + H]+: 267.1162; found: 267.1163. 1H NMR (300 MHz, CDCl3): δ = 7.29 (5 H, m), 5.97 (1 H, m), 5.72 (1 H, m), 3.67 (1 H, d, J = 4.2 Hz), 3.99 (1 H, dd, J = 4.2, 9.6 Hz), 2.73 (6 H, s), 1.56 (3 H, d, J = 6.6 Hz). 13C NMR (75 MHz, CDCl3): δ = 133.9, 128.9, 127.7, 127.2, 126.1, 122.8, 53.04, 48.96, 38.48, 17.96.
1-(2′-Dimethylamine-2′-sulfonyl)-2-isopropenyl-3-phenylaziridine (2c)
Assignments are of the trans diastereomer. IR (thin film): νmax = 1180, 1342, 1453 cm-1. MS (EI/Cl): m/z (%) = 267 (100) [M + H]. HRMS: m/z calcd for C13H18S1O2N2 [M + H]+: 267.1162; found: 267.1163. 1H NMR (400 MHz, CDCl3): δ = 7.37 (5 H, m), 5.29 (1 H, s), 5.20 (1 H, s), 3.87 (1 H, d, J = 4.8 Hz), 3.51 (1 H, d, J = 4.8 Hz), 2.79 (6 H, s), 1.97 (3 H, s). 13C NMR (100 MHz, CDCl3): δ = 138.0, 136.2, 129.7, 128.4, 127.8, 117.2, 52.3, 48.0, 38.2, 20.4.
1-(2′-Dimethylamine-2′-sulfonyl)-2-(2′′-methyl-propenyl)-3-phenylaziridine (2d)
Assignments are of the trans diastereomer. IR (thin film): νmax = 1180, 1343, 1453 cm-1. MS (EI/Cl): m/z (%) = 281 (100) [M + H]. HRMS: m/z calcd for C14H20S1O2N2 [M + H]+: 281.1318; found: 281.1320. 1H NMR (300 MHz, CDCl3): δ = 7.30-7.19 (5 H, m), 4.62 (1 H, d, J = 8.6 Hz), 3.62 (1 H, d, J = 7.2 Hz), 3.57 (1 H, dd, J = 7.2, 8.6 Hz), 2.84 (6 H, s), 1.72 (3 H, s), 1.57 (3 H, s). 13C NMR (75 MHz, CDCl3): δ = 127.6, 127.3, 127.1, 126.8, 115, 45.4, 42.8, 37.7, 24.9, 17.59.
1-(2′-Dimethylamine-2′-sulfonyl)-2-phenyl-3-styryl-aziridine (2e)
Assignments are of the trans diastereomer. IR (thin film): νmax = 1153, 1344, 1452 cm-1. MS (EI/Cl): m/z (%) = 329 (100) [M + H]. HRMS: m/z calcd for C18H20S1O2N2 [M + H]+: 329.1318; found: 329.1320. 1H NMR (400 MHz, CDCl3): δ = 7.40-7.10 (10 H, m), 6.78 (1 H, d, J = 15.6 Hz), 6.40 (1 H, dd, J = 9.2, 15.6 Hz), 3.8 (1 H, d, J = 3.6 Hz), 3.28 (1 H, dd, J = 3.6, 9.2 Hz), 2.79 (6 H, s). 13C NMR (100 MHz, CDCl3): δ = 137.1, 136.0, 133.8, 129.1, 128.9, 128.4, 128.2, 127.6, 127.1, 121.9, 48.0, 46.2, 39.0.